Economic TimesNovartis Says Final-Phase Study on Heart Drug Was SuccessfulBusinessweekNovartis AG (NOVN) said a final-phase clinical trial on a treatment for chronic heart failure met its goal and the drugmaker plans to ask global regulators for marketing approval for the drug. Novartis is ending the test early as the results show patients treated …Novartis set to close heart drug study early after strong resultsReutersNovartis Heart Failure Pill Trial Ends Early on Positive ResultWall Street JournalNovartis: DMC recommends early closure of PARADIGM-HF studyRTT NewsMarketWatchall 9 news articles …Read Full Story
Novartis Says Final-Phase Study on Heart Drug Was Successful - Businessweek
Real Estate of Cebu
